Conference Coverage
Conference Coverage
Drugs to prevent versus those to treat migraine might not share targets
The distinct molecular events in each phase of migraine suggest the prevention and treatment targets differ.
Conference Coverage
Adolescents with migraine need smooth handoff to adult care
One goal of migraine management in adolescents and young adults should be to prevent adulthood chronicity.
Conference Coverage
Novel myasthenia gravis therapies bring opportunities, challenges
Minimal disease manifestation is meaningful for patients, but should be weighed against potential side effects.
Conference Coverage
Avoid adding to minority stress when treating headache in LGBTQIA+ patients
To address headache in LBGTQIA+ patients, inclusive behavior can set the stage of collaboration toward control.
Conference Coverage
Newly approved myasthenia gravis drug shows sustained benefits in early responders
“This self-administered medication allows patients to be more independent and can even travel since it is not dependent on an infusion center.”
Conference Coverage
Chemotherapy-induced peripheral neuropathy tied to compromised executive function
Chemotherapy-related mobility declines in CIPN survivors are likely due to both neuromuscular and executive dysfunction.
Conference Coverage
Artificial intelligence presents opportunities, challenges in neurologic practice
Programs can generate health care and research content, but require close supervision and an attitude of ‘trust, but verify.’
Conference Coverage
Blood pressure lowering reduces dementia risk
“This proven, effective intervention should be widely scaled up to reduce the global burden of dementia.”
Conference Coverage
Stroke patients benefit from neurologic music therapy
Neurologic music therapy improves mental health and increases neuroplasticity, when used in conjunction with stroke rehabilitation.
Conference Coverage
U.S. study finds unexpectedly high prevalence of myasthenia gravis
A study of the NIH All of Us database shows a higher prevalence of myasthenia gravis than what has been reported in previous studies.
Conference Coverage
‘Hidden’ cognitive impairments in DMD may worsen outcomes
Long waits for neuropsychiatric evaluations make it difficult to get help, but an NIH tool may help.